291 related articles for article (PubMed ID: 23154424)
1. Association and prognostic value of serum inflammation markers in patients with leukoplakia and oral cavity cancer.
Chang PY; Kuo YB; Wu TL; Liao CT; Sun YC; Yen TC; Chan EC
Clin Chem Lab Med; 2013 Jun; 51(6):1291-300. PubMed ID: 23154424
[TBL] [Abstract][Full Text] [Related]
2. Comparison of Serum Fucose Levels in Leukoplakia and Oral Cancer Patients.
Rai NP; Anekar J; Shivaraja Shankara YM; Divakar DD; Al Kheraif AA; Ramakrishnaiah R; Sebastian R; Raj AC; Al-Hazmi A; Mustafa SM
Asian Pac J Cancer Prev; 2015; 16(17):7497-500. PubMed ID: 26625751
[TBL] [Abstract][Full Text] [Related]
3. Elevated level of serum growth differentiation factor 15 is associated with oral leukoplakia and oral squamous cell carcinoma.
Yang CZ; Ma J; Luo QQ; Neskey DM; Zhu DW; Liu Y; Myers JN; Zhang CP; Zhang ZY; Zhong LP
J Oral Pathol Med; 2014 Jan; 43(1):28-34. PubMed ID: 23710769
[TBL] [Abstract][Full Text] [Related]
4. Circulating Anti-Matrix Metalloproteinase-7 Antibodies May Be a Potential Biomarker for Oral Squamous Cell Carcinoma.
Jiang T; Xie P; Liu H
J Oral Maxillofac Surg; 2016 Mar; 74(3):650-7. PubMed ID: 26454036
[TBL] [Abstract][Full Text] [Related]
5. Salivary Tumour Necrosis Factor-α as a Biomarker in Oral Leukoplakia and Oral Squamous Cell Carcinoma.
G D; Nandan SRK; Kulkarni PG
Asian Pac J Cancer Prev; 2019 Jul; 20(7):2087-2093. PubMed ID: 31350970
[TBL] [Abstract][Full Text] [Related]
6. Salivary Biomarkers for Detection of Oral Squamous Cell Carcinoma in a Taiwanese Population.
Gleber-Netto FO; Yakob M; Li F; Feng Z; Dai J; Kao HK; Chang YL; Chang KP; Wong DT
Clin Cancer Res; 2016 Jul; 22(13):3340-7. PubMed ID: 26847061
[TBL] [Abstract][Full Text] [Related]
7. Association of serum and salivary tumor necrosis factor-α with histological grading in oral cancer and its role in differentiating premalignant and malignant oral disease.
Krishnan R; Thayalan DK; Padmanaban R; Ramadas R; Annasamy RK; Anandan N
Asian Pac J Cancer Prev; 2014; 15(17):7141-8. PubMed ID: 25227804
[TBL] [Abstract][Full Text] [Related]
8. Elevated Serum Gas6 Is a Novel Prognostic Biomarker in Patients with Oral Squamous Cell Carcinoma.
Jiang T; Liu G; Wang L; Liu H
PLoS One; 2015; 10(7):e0133940. PubMed ID: 26207647
[TBL] [Abstract][Full Text] [Related]
9. Serum metabolomics in oral leukoplakia and oral squamous cell carcinoma.
Sridharan G; Ramani P; Patankar S
J Cancer Res Ther; 2017; 13(3):556-561. PubMed ID: 28862226
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of serum lipids and lipoproteins as prognosticators in leukoplakia.
Ganavi BS; Patil S; Rao RS
J Contemp Dent Pract; 2014 May; 15(3):294-9. PubMed ID: 25307809
[TBL] [Abstract][Full Text] [Related]
11. Galectin-9 as an important marker in the differential diagnosis between oral squamous cell carcinoma, oral leukoplakia and oral lichen planus.
Muniz JM; Bibiano Borges CR; Beghini M; de Araújo MS; Miranda Alves P; de Lima LM; Pereira SA; Nogueira RD; Napimoga MH; Rodrigues V; Rodrigues DB
Immunobiology; 2015 Aug; 220(8):1006-11. PubMed ID: 25956455
[TBL] [Abstract][Full Text] [Related]
12. Monitoring carcinogenesis in a case of oral squamous cell carcinoma using a panel of new metabolic blood biomarkers as liquid biopsies.
Grimm M; Hoefert S; Krimmel M; Biegner T; Feyen O; Teriete P; Reinert S
Oral Maxillofac Surg; 2016 Sep; 20(3):295-302. PubMed ID: 26875085
[TBL] [Abstract][Full Text] [Related]
13. Circulating microRNA-21 (MIR-21) and phosphatase and tensin homolog (PTEN) are promising novel biomarkers for detection of oral squamous cell carcinoma.
Ren W; Qiang C; Gao L; Li SM; Zhang LM; Wang XL; Dong JW; Chen C; Liu CY; Zhi KQ
Biomarkers; 2014 Nov; 19(7):590-6. PubMed ID: 25174622
[TBL] [Abstract][Full Text] [Related]
14. Hemoglobin, C-reactive protein and ferritin in patients with oral carcinoma and their clinical significance - A prospective clinical study.
Blatt S; Schön H; Sagheb K; Kämmerer PW; Al-Nawas B; Schiegnitz E
J Craniomaxillofac Surg; 2018 Feb; 46(2):207-212. PubMed ID: 29287926
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical analysis of neutrophils, interleukin-17, matrix metalloproteinase-9, and neoformed vessels in oral squamous cell carcinoma.
Silva RNF; Dallarmi LB; Araujo AKC; Alencar RCG; Mendonça EF; Silva TA; Batista AC; Costa NL
J Oral Pathol Med; 2018 Oct; 47(9):856-863. PubMed ID: 29964301
[TBL] [Abstract][Full Text] [Related]
16. Serum Annexin A2 Level Is Associated With Diagnosis and Prognosis in Patients With Oral Squamous Cell Carcinoma.
Zhang W; Gao C; Zhang S; Fang G
J Oral Maxillofac Surg; 2017 May; 75(5):1081-1087. PubMed ID: 27889534
[TBL] [Abstract][Full Text] [Related]
17. Serum miR-483-5p: a novel diagnostic and prognostic biomarker for patients with oral squamous cell carcinoma.
Xu H; Yang Y; Zhao H; Yang X; Luo Y; Ren Y; Liu W; Li N
Tumour Biol; 2016 Jan; 37(1):447-53. PubMed ID: 26224475
[TBL] [Abstract][Full Text] [Related]
18. Serum CCL2 and CCL3 as potential biomarkers for the diagnosis of oral squamous cell carcinoma.
Ding L; Li B; Zhao Y; Fu YF; Hu EL; Hu QG; Ni YH; Hou YY
Tumour Biol; 2014 Oct; 35(10):10539-46. PubMed ID: 25060177
[TBL] [Abstract][Full Text] [Related]
19. Serum markers of CYFRA 21-1 and C-reactive proteins in oral squamous cell carcinoma.
Hsu YP; Hsieh CH; Chien HT; Lai CH; Tsao CK; Liao CT; Kang CJ; Wang HM; Chang JT; Huang SF
World J Surg Oncol; 2015 Aug; 13():253. PubMed ID: 26292957
[TBL] [Abstract][Full Text] [Related]
20. Proinflammatory cytokines as serum biomarker in oral carcinoma-A prospective multi-biomarker approach.
Schiegnitz E; Kämmerer PW; Schön H; Blatt S; Berres M; Sagheb K; Al-Nawas B
J Oral Pathol Med; 2018 Mar; 47(3):268-274. PubMed ID: 29272054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
